Comparative clinical and cost-effectiveness of drug therapies for relapsing-remitting multiple sclerosis project protocol
The Canadian Agency for Drugs and Technologies in Health (CADTH) will undertake a systematic review to compare the efficacy and safety of disease-modifying agents for patients with relapsing-remitting multiple sclerosis (RRMS), and will examine their cost-effectiveness. The review will include disea...
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2012, December 2012
|
| Series: | CADTH therapeutic review
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references